Location History:
- Essex, GB (2010)
- London, GB (2006 - 2018)
Company Filing History:
3 out of 89 
1 out of 26 
1 out of 5 Years Active: 2006-2018
Title: Christoph Thiemermann: Innovator in Trauma Treatment
Introduction
Christoph Thiemermann is a distinguished inventor based in London, GB, known for his significant contributions to medical innovation. With a total of five patents to his name, Thiemermann has focused his research on the therapeutic potential of artemisinin and its derivatives in treating complex medical conditions, particularly those associated with trauma.
Latest Patents
Thiemermann's most recent patented invention centers around "Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions." This innovation addresses the treatment of trauma haemorrhage and trauma-induced organ injury, focusing on disorders such as stroke, burns, and brain injury. The invention also extends to myocardial infarction and coronary heart disease, utilizing the anti-malarial properties of artemisinin. Additionally, it pertains to applications in coronary artery bypass surgery, heart transplantation, and conditions linked to ischaemia-reperfusion, showcasing the versatility and therapeutic potential of artemisinin in critical medical situations.
Career Highlights
Thiemermann has been pivotal in advancing medicinal research, holding key positions in notable institutions such as Queen Mary University of London and CSL Behring AG. His work has consistently contributed to the understanding and treatment of severe medical conditions, solidifying his reputation as an innovator in the field.
Collaborations
Throughout his career, Thiemermann has collaborated with esteemed professionals, including Gillian Cockerill and Salvatore Cuzzocrea. These partnerships have been vital in driving forward pioneering research and facilitating advancements in the therapeutic applications of his inventions.
Conclusion
Christoph Thiemermann exemplifies the spirit of innovation in medicine, with a strong focus on leveraging artemisinin for impactful treatments in trauma care and beyond. His dedicated research and collaborative efforts continue to shape the future of medical interventions, offering hope for improved outcomes in critical health scenarios.